357 related articles for article (PubMed ID: 17891164)
1. Cannabinoid self-administration in rats: sex differences and the influence of ovarian function.
Fattore L; Spano MS; Altea S; Angius F; Fadda P; Fratta W
Br J Pharmacol; 2007 Nov; 152(5):795-804. PubMed ID: 17891164
[TBL] [Abstract][Full Text] [Related]
2. Drug- and cue-induced reinstatement of cannabinoid-seeking behaviour in male and female rats: influence of ovarian hormones.
Fattore L; Spano MS; Altea S; Fadda P; Fratta W
Br J Pharmacol; 2010 Jun; 160(3):724-35. PubMed ID: 20590575
[TBL] [Abstract][Full Text] [Related]
3. Strain and schedule-dependent differences in the acquisition, maintenance and extinction of intravenous cannabinoid self-administration in rats.
Deiana S; Fattore L; Spano MS; Cossu G; Porcu E; Fadda P; Fratta W
Neuropharmacology; 2007 Feb; 52(2):646-54. PubMed ID: 17098261
[TBL] [Abstract][Full Text] [Related]
4. Cannabis reward: biased towards the fairer sex?
McGregor IS; Arnold JC
Br J Pharmacol; 2007 Nov; 152(5):562-4. PubMed ID: 17891161
[TBL] [Abstract][Full Text] [Related]
5. Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats.
Fattore L; Cossu G; Martellotta CM; Fratta W
Psychopharmacology (Berl); 2001 Aug; 156(4):410-6. PubMed ID: 11498718
[TBL] [Abstract][Full Text] [Related]
6. Monitoring extracellular dopamine in the rat nucleus accumbens shell and core during acquisition and maintenance of intravenous WIN 55,212-2 self-administration.
Lecca D; Cacciapaglia F; Valentini V; Di Chiara G
Psychopharmacology (Berl); 2006 Sep; 188(1):63-74. PubMed ID: 16850116
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model.
Lefever TW; Marusich JA; Antonazzo KR; Wiley JL
Pharmacol Biochem Behav; 2014 Mar; 118():30-5. PubMed ID: 24412835
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.
Gamaleddin I; Wertheim C; Zhu AZ; Coen KM; Vemuri K; Makryannis A; Goldberg SR; Le Foll B
Addict Biol; 2012 Jan; 17(1):47-61. PubMed ID: 21521420
[TBL] [Abstract][Full Text] [Related]
9. Involvement of kappa/dynorphin system in WIN 55,212-2 self-administration in mice.
Mendizábal V; Zimmer A; Maldonado R
Neuropsychopharmacology; 2006 Sep; 31(9):1957-66. PubMed ID: 16292318
[TBL] [Abstract][Full Text] [Related]
10. Sex-specific differences in cannabinoid-induced extracellular-signal-regulated kinase phosphorylation in the cingulate cortex, prefrontal cortex, and nucleus accumbens of Lister Hooded rats.
Rosas M; Porru S; Giugliano V; Antinori S; Scheggi S; Fadda P; Fratta W; Acquas E; Fattore L
Behav Pharmacol; 2018 Sep; 29(6):473-481. PubMed ID: 29595540
[TBL] [Abstract][Full Text] [Related]
11. CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat.
Spano MS; Fattore L; Cossu G; Deiana S; Fadda P; Fratta W
Br J Pharmacol; 2004 Oct; 143(3):343-50. PubMed ID: 15339858
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid self-administration increases dopamine release in the nucleus accumbens.
Fadda P; Scherma M; Spano MS; Salis P; Melis V; Fattore L; Fratta W
Neuroreport; 2006 Oct; 17(15):1629-32. PubMed ID: 17001282
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats.
Fattore L; Spano M; Melis V; Fadda P; Fratta W
Br J Pharmacol; 2011 Aug; 163(7):1550-62. PubMed ID: 21518339
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats.
Fattore L; Spano S; Cossu G; Deiana S; Fadda P; Fratta W
Neuropharmacology; 2005 Jun; 48(8):1097-104. PubMed ID: 15910886
[TBL] [Abstract][Full Text] [Related]
15. Potentiation by WIN 55,212-2 of GABA-activated currents in rat trigeminal ganglion neurones.
Li ZW; Zhang J; Ouyang CH; Li CY; Zhao FB; Liu YW; Ai YX; Hu WP
Br J Pharmacol; 2009 Dec; 158(8):1904-10. PubMed ID: 19917064
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress.
Ganon-Elazar E; Akirav I
Neuropsychopharmacology; 2012 Jan; 37(2):456-66. PubMed ID: 21918506
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors.
Abalo R; Cabezos PA; Vera G; López-Miranda V; Herradón E; Martín-Fontelles MI
Neurogastroenterol Motil; 2011 May; 23(5):457-67, e177. PubMed ID: 21303434
[TBL] [Abstract][Full Text] [Related]
18. Ethanol self-administration is regulated by CB1 receptors in the nucleus accumbens and ventral tegmental area in alcohol-preferring AA rats.
Malinen H; Hyytiä P
Alcohol Clin Exp Res; 2008 Nov; 32(11):1976-83. PubMed ID: 18782338
[TBL] [Abstract][Full Text] [Related]
19. Chronic cannabinoid administration in vivo compromises extinction of fear memory.
Lin HC; Mao SC; Chen PS; Gean PW
Learn Mem; 2008 Dec; 15(12):876-84. PubMed ID: 19050159
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid agonists but not inhibitors of endogenous cannabinoid transport or metabolism enhance the reinforcing efficacy of heroin in rats.
Solinas M; Panlilio LV; Tanda G; Makriyannis A; Matthews SA; Goldberg SR
Neuropsychopharmacology; 2005 Nov; 30(11):2046-57. PubMed ID: 15870833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
